Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription 23.05.2022 3 AJR Am J Roentgenol 2 Biochem Biophys Res Commun 4 BMC Gastroenterol 5 Br J Surg 1 Cancer 2 Cancer Res 1 Dig Dis 3 Eur Radiol 5 Gastroenterology 2 Gut 15 Hepatology 1 Indian J Gastroenterol 1 Int J Cancer 1 J Clin Oncol 1 J Comput Assist Tomogr 2 J Gastroenterol Hepatol 9 J Hepatol 2 PLoS One 4 Radiology 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DASTMALCHIAN S, Aryafar H, Tavri S
   Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic Shunt Procedures: A Review.
   AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
   PubMed         Abstract available
   
   
2. HULL NC
   Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in Children With Predisposing Conditions.
   AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
   PubMed        
   
   
3. FETZER DT
   Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes.
   AJR Am J Roentgenol. 2022;218:761.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

4. KE X, Zhang R, Li P, Zuo L, et al
   Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism.
   Biochem Biophys Res Commun. 2022;610:49-55.
   PubMed         Abstract available
   
   
5. GAO L, Zhang Y, Gao X, Xu L, et al
   Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis.
   Biochem Biophys Res Commun. 2022;610:176-181.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. HUANG Y, Cai J, Ha F, Guo B, et al
   Characteristics of acute kidney injury and its impact on outcome in patients with acute-on-chronic liver failure.
   BMC Gastroenterol. 2022;22:231.
   PubMed         Abstract available
   
   
7. KASACKA I, Piotrowska Z, Domian N, Lewandowska A, et al
   Immunohistochemical identification and assessment of the location of leptin, visfatin and chemerin in the liver of men with different body mass index.
   BMC Gastroenterol. 2022;22:233.
   PubMed         Abstract available
   
   
8. SUGIYAMA A, Kurisu A, E B, Ouoba S, et al
   Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups.
   BMC Gastroenterol. 2022;22:241.
   PubMed         Abstract available
   
   
9. LIU S, Xie X, Tang X, He H, et al
   Non-tuberculosis extensive abdominal lymph node calcification leading to portal hypertension with esophageal and gastric variceal bleeding: a rare case report.
   BMC Gastroenterol. 2022;22:245.
   PubMed         Abstract available
   
   

   
   Br J Surg

10. WANG R, Quan Z, Zheng T, Wang K, et al
    Pathophysiological mechanisms of ALPPS: experimental model.
    Br J Surg. 2022;109:510-519.
    PubMed         Abstract available
    
    
11. SALEH NB, Golse N, Abdallah M, Veziant J, et al
    Preoperative morphometric measurements of liver vasculature to predict postoperative liver failure: bicentric study.
    Br J Surg. 2022;109:554-555.
    PubMed        
    
    
12. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
    Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
    Br J Surg. 2022;109:483-485.
    PubMed        
    
    
13. YOU J, Wu S, Fu Y, Meng L, et al
    Wrapping of the hepatic artery using the round ligament during laparoscopic pancreatoduodenectomy to prevent postpancreatectomy haemorrhage.
    Br J Surg. 2022 May 17. pii: 6586618. doi: 10.1093.
    PubMed        
    
    
14. WEI F
    Erratum to: Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2022;109:551.
    PubMed        
    
    

    
    Cancer

15. SHORT SS, Kastenberg ZJ, Wei G, Bondoc A, et al
    Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
    Cancer. 2022 May 13. doi: 10.1002/cncr.34256.
    PubMed         Abstract available
    
    

    
    Cancer Res

16. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
    Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
    Cancer Res. 2022;82:1953-1968.
    PubMed         Abstract available
    
    
17. LIU Z, Ye Y, Liu Y, Liu Y, et al
    RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1.
    Cancer Res. 2022;82:1937-1952.
    PubMed         Abstract available
    
    

    
    Dig Dis

18. SEHGAL R, Kaur N, Ramakrishna G, Trehanpati N, et al
    Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
    Dig Dis. 2022;40:301-312.
    PubMed         Abstract available
    
    

    
    Eur Radiol

19. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
    PubMed         Abstract available
    
    
20. PAN J, Li W, Gu L, Liu C, et al
    Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
    Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
    PubMed         Abstract available
    
    
21. WEI H, Jiang H, Qin Y, Wu Y, et al
    Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
    PubMed         Abstract available
    
    

    
    Gastroenterology

22. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
    Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
    Gastroenterology. 2022;162:1858-1875.
    PubMed         Abstract available
    
    
23. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.
    PubMed        
    
    
24. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
    PubMed        
    
    
25. NATSUI K, Maruyama M, Terai S
    Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
    PubMed        
    
    
26. HU S, Molina L, Tao J, Liu S, et al
    NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
    PubMed         Abstract available
    
    

    
    Gut

27. GONZALEZ-RELLAN MJ, Novoa E, da Silva Lima N, Rodriguez A, et al
    Hepatic p63 regulates glucose metabolism by repressing SIRT1.
    Gut. 2022 May 17. pii: gutjnl-2021-326620. doi: 10.1136/gutjnl-2021-326620.
    PubMed         Abstract available
    
    
28. MARTIN-SERRANO MA, Kepecs B, Torres-Martin M, Bramel ER, et al
    Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
    Gut. 2022 May 18. pii: gutjnl-2021-326514. doi: 10.1136/gutjnl-2021-326514.
    PubMed         Abstract available
    
    

    
    Hepatology

29. KIM KE, Lee J, Shin HJ, Jeong EA, et al
    Lipocalin-2 Activates Hepatic stellate cells and Promotes Non-alcoholic Steatohepatitis in High-Fat Diet-Fed ob/ob mice.
    Hepatology. 2022 May 13. doi: 10.1002/hep.32569.
    PubMed         Abstract available
    
    
30. BAJAJ JS, Rodriguez MP, Fagan A, McGeorge S, et al
    Impact of Bacterial Infections and SBP Prophylaxis on Phage-Bacterial Dynamics in Cirrhosis.
    Hepatology. 2022 May 13. doi: 10.1002/hep.32571.
    PubMed         Abstract available
    
    
31. MURAI H, Kodama T, Maesaka K, Tange S, et al
    Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.
    Hepatology. 2022 May 14. doi: 10.1002/hep.32573.
    PubMed         Abstract available
    
    
32. PILLING LC, Atkins JL, Melzer D
    Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: associations in a large community cohort.
    Hepatology. 2022 May 14. doi: 10.1002/hep.32575.
    PubMed         Abstract available
    
    
33. ALVA-RUIZ R, Wu T, Idalsoaga F, Ramkissoon R, et al
    Hepatology highlights.
    Hepatology. 2022;75:1363-1364.
    PubMed        
    
    
34. XU W, Cui C, Cui C, Chen Z, et al
    Hepatocellular Cystathionine gamma lyase/Hydrogen sulfide Attenuates Non-Alcoholic Fatty Liver Disease by Activating Farnesoid X Receptor.
    Hepatology. 2022 May 19. doi: 10.1002/hep.32577.
    PubMed         Abstract available
    
    
35. PSARAKI A, Ntari L, Karakostas C, Korrou-Karava D, et al
    Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases.
    Hepatology. 2022;75:1590-1603.
    PubMed         Abstract available
    
    
36. VILAR-GOMEZ E, Nephew LD, Vuppalanchi R, Gawrieh S, et al
    High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population.
    Hepatology. 2022;75:1491-1506.
    PubMed         Abstract available
    
    
37. QIAN Q, Li Y, Fu J, Leng D, et al
    Switch-associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1.
    Hepatology. 2022;75:1507-1522.
    PubMed         Abstract available
    
    
38. SANDAHL TD, Gormsen LC, Kjaergaard K, Vendelbo MH, et al
    The pathophysiology of Wilson's disease visualized: A human (64) Cu PET study.
    Hepatology. 2022;75:1461-1470.
    PubMed         Abstract available
    
    
39. LAI JC, Shui AM, Duarte-Rojo A, Ganger DR, et al
    Frailty, Mortality, and Healthcare Utilization after Liver Transplantation: From the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2021 Dec 4. doi: 10.1002/hep.32268.
    PubMed         Abstract available
    
    
40. JULIEN J, Ayer T, Tapper EB, Barbosa C, et al
    Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study.
    Hepatology. 2022;75:1480-1490.
    PubMed         Abstract available
    
    
41. TESTINO G
    Letter to the editor: Chronic liver disease among adolescents and young adults: Alcohol use disorder identification.
    Hepatology. 2022;75:1662-1663.
    PubMed        
    
    
42. EFE C, Harputluoglu M, Karadag Soylu N, Yilmaz S, et al
    Liver transplantation following SARS-CoV-2 vaccination-induced liver failure.
    Hepatology. 2022 Feb 17. doi: 10.1002/hep.32409.
    PubMed        
    
    
43. IBRAHIM SH, Kamath BM, Loomes KM, Karpen SJ, et al
    Cholestatic Liver Diseases of Genetic Etiology: Advances and Controversies.
    Hepatology. 2022 Mar 1. doi: 10.1002/hep.32437.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

44. THONGTAN T, Deb A, Vutthikraivit W, Laoveeravat P, et al
    Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Indian J Gastroenterol. 2022;41:119-126.
    PubMed         Abstract available
    
    

    
    Int J Cancer

45. WU H, Zheng X, Pan T, Yang X, et al
    Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti-PD-1 based immunotherapy in hepatocellular carcinoma.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34118.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

46. CHIANG CH, Chiang CH, Chiang CH
    Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?
    J Clin Oncol. 2022 May 12:JCO2200179. doi: 10.1200/JCO.22.00179.
    PubMed        
    
    

    
    J Comput Assist Tomogr

47. HAZHIRKARZAR B, Shaghaghi M, Baghdadi A, Ghadimi M, et al
    Can Posttransarterial Chemoembolization Volumetric Oil Deposition on Computed Tomography Predict Treatment Response on Magnetic Resonance Imaging in Leiomyosarcoma Metastases to the Liver?
    J Comput Assist Tomogr. 2022;46:327-332.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

48. CHAN SL, Wong N, Lam WKJ, Kuang M, et al
    Personalized treatment for hepatocellular carcinoma: Current status and Future perspectives.
    J Gastroenterol Hepatol. 2022 May 15. doi: 10.1111/jgh.15889.
    PubMed         Abstract available
    
    
49. CHOI AY, Kolb J, Shah S, Chahine A, et al
    Endoscopic ultrasound-guided portal pressure gradient with liver biopsy: 6 years of endo-hepatology in practice.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15875.
    PubMed         Abstract available
    
    

    
    J Hepatol

50. YEUNG A, Palmateer NE, Dillon JF, McDonald SA, et al
    Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557].
    J Hepatol. 2022 May 9. pii: S0168-8278(22)00248.
    PubMed        
    
    
51. SUMAZIN P, Peters TL, Sarabia SF, Kim HR, et al
    Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
    J Hepatol. 2022 May 13. pii: S0168-8278(22)00275.
    PubMed         Abstract available
    
    
52. SEUNG KJ, Franke MF, Hewison C, Huerga H, et al
    Corrigendum to 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029].
    J Hepatol. 2022 May 14. pii: S0168-8278(22)00247.
    PubMed        
    
    
53. GURI Y, Vosbeck J, Dickenmann M, Jetter A, et al
    Exacerbation of Familial Intrahepatic Cholestasis in Conjunction with COVID-19 Vaccination.
    J Hepatol. 2022 May 16. pii: S0168-8278(22)00313.
    PubMed        
    
    
54. TERRAULT NA, Dufour JF, Schwabe RF, Wong VW, et al
    Breakthroughs in hepatology.
    J Hepatol. 2022;76:1247-1248.
    PubMed        
    
    
55. LISMAN T, Caldwell SH, Intagliata NM
    Haemostatic alterations and management of haemostasis in patients with cirrhosis.
    J Hepatol. 2022;76:1291-1305.
    PubMed         Abstract available
    
    
56. CARACENI P, O'Brien A, Gines P
    Long-term albumin treatment in patients with cirrhosis and ascites.
    J Hepatol. 2022;76:1306-1317.
    PubMed         Abstract available
    
    
57. CALDERARO J, Seraphin TP, Luedde T, Simon TG, et al
    Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.
    J Hepatol. 2022;76:1348-1361.
    PubMed         Abstract available
    
    
58. ANSTEE QM, Castera L, Loomba R
    Impact of non-invasive biomarkers on hepatology practice: Past, present and future.
    J Hepatol. 2022;76:1362-1378.
    PubMed         Abstract available
    
    

    
    PLoS One

59. OH MK, Joo H, Kim IS
    Prohaptoglobin inhibits the transforming growth factor-beta-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
    PLoS One. 2022;17:e0266409.
    PubMed         Abstract available
    
    
60. ORR CE, Wang PL, Chen L, Wang T, et al
    Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma.
    PLoS One. 2022;17:e0267474.
    PubMed         Abstract available
    
    

    
    Radiology

61. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.
    PubMed        
    
    
62. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    PubMed         Abstract available
    
    
63. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.
    PubMed        
    
    
64. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    PubMed         Abstract available
    
    

    
    Transplantation

65. WANG Z, Liu D, Yan Q, Liu F, et al
    Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression.
    Transplantation. 2022 May 11. pii: 00007890-990000000-00043.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: